Our top pick for
Building a portfolio
Mesa Laboratories, Inc is a scientific & technical instruments business based in the US. Mesa Laboratories shares (MLAB) are listed on the NASDAQ and all prices are listed in US Dollars. Mesa Laboratories employs 460 staff and has a trailing 12-month revenue of around USD$127.7 million.
|Latest market close||USD$267.73|
|52-week range||USD$181.5599 - USD$292.0173|
|50-day moving average||USD$272.5411|
|200-day moving average||USD$249.1805|
|Wall St. target price||USD$281.5|
|Dividend yield||USD$0.64 (0.24%)|
|Earnings per share (TTM)||USD$0.31|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-12)||-9.79%|
|1 month (2020-12-22)||-6.22%|
|3 months (2020-10-20)||-2.68%|
|6 months (2020-07-20)||17.43%|
|1 year (2020-01-18)||N/A|
|2 years (2019-01-18)||23.92%|
|3 years (2018-01-19)||100.94%|
|5 years (2016-01-20)||199.68%|
Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mesa Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 736x. In other words, Mesa Laboratories shares trade at around 736x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Mesa Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$32.1 million.
The EBITDA is a measure of a Mesa Laboratories's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$127.7 million|
|Operating margin TTM||11.9%|
|Gross profit TTM||USD$73.4 million|
|Return on assets TTM||1.94%|
|Return on equity TTM||-0.83%|
|Market capitalisation||USD$1.4 billion|
TTM: trailing 12 months
There are currently 347,410 Mesa Laboratories shares held short by investors – that's known as Mesa Laboratories's "short interest". This figure is 0.6% up from 345,188 last month.
There are a few different ways that this level of interest in shorting Mesa Laboratories shares can be evaluated.
Mesa Laboratories's "short interest ratio" (SIR) is the quantity of Mesa Laboratories shares currently shorted divided by the average quantity of Mesa Laboratories shares traded daily (recently around 23844.200411805). Mesa Laboratories's SIR currently stands at 14.57. In other words for every 100,000 Mesa Laboratories shares traded daily on the market, roughly 14570 shares are currently held short.
However Mesa Laboratories's short interest can also be evaluated against the total number of Mesa Laboratories shares, or, against the total number of tradable Mesa Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mesa Laboratories's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Mesa Laboratories shares in existence, roughly 70 shares are currently held short) or 0.0848% of the tradable shares (for every 100,000 tradable Mesa Laboratories shares, roughly 85 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Mesa Laboratories.
Find out more about how you can short Mesa Laboratories stock.
We're not expecting Mesa Laboratories to pay a dividend over the next 12 months.
Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $181.5599 up to $292.0173. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.4105. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.